mirogabalin: Clinical Trials

9 trials of mirogabalin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 9 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 39Completed 9

Follow mirogabalin: new trials by email Literature Review of mirogabalin trials Research Report on mirogabalin

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled 14-week Study of DS-5565 in Chinese Patients With Diabetic Peripheral Neuropathic Pain
Mirogabalin, Placebo - Diabetic Peripheral Neuropathic Pain
Phase 3CompletedDaiichi Sankyo Co., Ltd.3932019-09-182022-10-24
Study of Mirogabalin for Central Neuropathic Pain
Placebo, Mirogabalin - Central Neuropathic Pain
Phase 3CompletedDaiichi Sankyo Co., Ltd.3002019-03-122024-10-21
DS-5565 Phase III Study for Renal Impairment in Japanese Subjects
DS-5565 - Diabetic Peripheral Neuropathic Pain, Post-herpetic Neuralgia
Phase 3CompletedDaiichi Sankyo Co., Ltd.352015-12-012021-05-13
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
DS-5565, Placebo - Fibromyalgia
Phase 3CompletedDaiichi Sankyo562015-06-262020-11-24
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
DS-5565 - Pain Associated With Fibromyalgia
Phase 3CompletedDaiichi Sankyo24852015-02-042020-07-23
Treatment of Pain Associated With Fibromyalgia
DS-5565, Pregabalin, Placebo tablet - Pain Associated With Fibromyalgia
Phase 3CompletedDaiichi Sankyo13012015-01-162020-11-09
DS-5565 Phase III Study for Diabetic Peripheral Neuropathic Pain
DS-5565, placebo - Diabetic Peripheral Neuropathic Pain
Phase 3CompletedDaiichi Sankyo Co., Ltd.8542015-01-012020-11-02
Treatment of Pain Associated With Fibromyalgia
DS-5565, Pregabalin, Placebo tablet - Pain Associated With Fibromyalgia
Phase 3CompletedDaiichi Sankyo12702014-11-012020-11-09
Treatment of Pain Associated With Fibromyalgia
DS-5565, Pregabalin, Placebo tablet - Pain Associated With Fibromyalgia
Phase 3CompletedDaiichi Sankyo12932014-10-272020-11-09

Conditions studied

Fibromyalgia (5)  ·  Pain (4)  ·  Neuralgia, Postherpetic (1)  ·  Renal Insufficiency (1)  ·  Renal Insufficiency, Chronic (1)

Sponsors

Daiichi Sankyo (5)  ·  Daiichi Sankyo Co., Ltd. (4)

Countries

United States (5)  ·  Bulgaria (3)  ·  Czechia (3)  ·  Hungary (3)  ·  Japan (3)  ·  Poland (3)  ·  Romania (3)  ·  Spain (3)  ·  Australia (2)  ·  Austria (2)  ·  Canada (2)  ·  Chile (2)  ·  Denmark (2)  ·  Estonia (2)  ·  Finland (2)

Results publications

PMID 31284771, PMID 32765056, PMID 34059327, PMID 36517235, PMID 37115464, PMID 38896199, PMID 38963656

NIH funding

2014 (1)